Reid G. Adler - 29 Dec 2023 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTGN	Common Stock	Award	$287	+167	+1.5%	$1.72	11,655	29 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.